Research Study

Post-Market Clinical Registry to Evaluate the Safety and Performance of MANTA Vascular Closure Device (VCD) Under Real World Conditions in the European Union (EU)
Principal Investigator 
David Wood

Overview

Body Locations and Systems 
Arteries
ClinicalTrials.gov# 
NCT03330002
Status 
Recruiting
Study Start/End 
Jun 19, 2018 to Dec 31, 2018
Locations 
Vancouver General Hospital
Name/Title 
Brady Robinson. Research Coordinator
Phone 
604-875-5106
Email Address 
brady.robinson@vch.ca
Purpose of Study 

Enrolling by Invitation Only

The aim of this observational post market study is to compile real world outcome data on the use of the Conformité Européenne (CE) marked MANTA Vascular Closure Device following percutaneous cardiac or peripheral procedures for large bore (10‐18F ID) interventional devices.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.